These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Examining the role of nasopharyngeal-associated lymphoreticular tissue (NALT) in mouse responses to vaccines. Cisney ED, Fernandez S, Hall SI, Krietz GA, Ulrich RG. J Vis Exp; 2012 Aug 01; (66):3960. PubMed ID: 22871688 [Abstract] [Full Text] [Related]
15. Intranasal vaccination of infant mice induces protective immunity in the absence of nasal-associated lymphoid tissue. Sabirov A, Metzger DW. Vaccine; 2008 Mar 17; 26(12):1566-76. PubMed ID: 18281130 [Abstract] [Full Text] [Related]
16. Induction of systemic immunity through nasal-associated lymphoid tissue (NALT) of mice intranasally immunized with Brucella abortus malate dehydrogenase-loaded chitosan nanoparticles. Shim S, Soh SH, Im YB, Ahn C, Park HT, Park HE, Park WB, Kim S, Yoo HS. PLoS One; 2020 Mar 17; 15(2):e0228463. PubMed ID: 32027689 [Abstract] [Full Text] [Related]
17. Potential of nasopharynx-associated lymphoid tissue for vaccine responses in the airways. Brandtzaeg P. Am J Respir Crit Care Med; 2011 Jun 15; 183(12):1595-604. PubMed ID: 21471092 [Abstract] [Full Text] [Related]
19. Studies on the generation and maintenance of mucosal cytotoxic T lymphocytes against human immunodeficiency virus type 1 Gag in mice. Yoshizawa I, Mizuochi T, Ogata A, Murakami M, Yagita H, Takahashi Y, Mizuochi T, Takemori T, Tsunetsugu-Yokota Y. AIDS Res Hum Retroviruses; 2003 Jun 15; 19(6):469-79. PubMed ID: 12882656 [Abstract] [Full Text] [Related]